Laurus Labs · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Analyst (Chetan Kapoor) directly challenged management on high scientist-to-project ratio (750 scientists for 60 projects vs industry average of 4-5 per project). Fixed costs not translating to revenues causing margin compression.
Multiple analysts raised concerns about negative operating cash flow in Q3 and INR 500 crore increase in net debt to ~INR 2,500 crore. Management acknowledged discrepancy and committed to clarify/submit revised numbers to exchanges.
Analyst (Rohit Jain) criticized repeated qualitative-only guidance over three quarters. Management declined to provide specific EBITDA margin targets despite gross margins at 54% and high fixed cost base.
Management acknowledged FY20-FY21 historical comparison expected to repeat but provided no timeline. Three quarters of below-expectation results without quantitative recovery roadmap testing investor patience.
